Egan W - Search Results

1

NMR Assays for Estimating the O-Acetyl Content of Meningococcal Polysaccharide Serogroup A in Quadrivalent Conjugate Vaccine Formulation.

Martini S, Aggravi M, Cianetti S, Egan W, Meppen M, Moriconi A, Simeone L, Berti F. Martini S, et al. Among authors: egan w. ACS Omega. 2019 Jul 29;4(7):12827-12832. doi: 10.1021/acsomega.9b01678. eCollection 2019 Jul 31. ACS Omega. 2019. PMID: 31460407 Free PMC article.

2

Correction to "NMR Assays for Estimating the O-Acetyl Content of Meningococcal Polysaccharide Serogroup A in Quadrivalent Conjugate Vaccine Formulation".

Martini S, Aggravi M, Cianetti S, Egan W, Meppen M, Moriconi A, Simeone L, Berti F. Martini S, et al. Among authors: egan w. ACS Omega. 2019 Sep 10;4(13):15771. doi: 10.1021/acsomega.9b02774. eCollection 2019 Sep 24. ACS Omega. 2019. PMID: 31572881 Free PMC article.

3

A new strategy for preparing a tailored meningococcal ACWY conjugate vaccine for clinical testing.

Moriconi A, Onnis V, Aggravi M, Parlati C, Bufali S, Cianetti S, Egan W, Khan A, Fragapane E, Meppen M, Paludi M, Berti F. Moriconi A, et al. Among authors: egan w. Vaccine. 2020 May 13;38(23):3930-3933. doi: 10.1016/j.vaccine.2020.04.005. Epub 2020 Apr 13. Vaccine. 2020. PMID: 32299720 No abstract available.

4

Physico-chemical characterization of polysaccharide vaccines.

Egan W. Egan W. Dev Biol (Basel). 2000;103:3-9. Dev Biol (Basel). 2000. PMID: 11214251 Review.

5

Review of workshop purposes and goals.

Egan W. Egan W. Dev Biol (Basel). 2001;106:3-4. Dev Biol (Basel). 2001. PMID: 11761244 No abstract available.

6

Potency assays for therapeutic live whole cell cancer vaccines.

Petricciani J, Egan W, Vicari G, Furesz J, Schild G. Petricciani J, et al. Among authors: egan w. Biologicals. 2007 Apr;35(2):107-13. doi: 10.1016/j.biologicals.2006.05.001. Epub 2006 Aug 1. Biologicals. 2007. PMID: 16882459 Review.

7

Aluminum salts in vaccines--US perspective.

Baylor NW, Egan W, Richman P. Baylor NW, et al. Among authors: egan w. Vaccine. 2002 May 31;20 Suppl 3:S18-23. doi: 10.1016/s0264-410x(02)00166-4. Vaccine. 2002. PMID: 12184360 Review.

8

Report of the international conference on next generation sequencing for adventitious virus detection in biologicals.

Khan AS, Benetti L, Blumel J, Deforce D, Egan WM, Knezevic I, Krause PR, Mallet L, Mayer D, Minor PD, Neels P, Wang G. Khan AS, et al. Among authors: egan wm. Biologicals. 2018 Sep;55:1-16. doi: 10.1016/j.biologicals.2018.08.002. Epub 2018 Aug 6. Biologicals. 2018. PMID: 30093175

9

New Cells for New Vaccines II: Focus on Respiratory Virus Diseases.

Egan W, Schild G. Egan W, et al. Biologicals. 2008 Nov;36(6):345. doi: 10.1016/j.biologicals.2008.07.003. Epub 2008 Aug 30. Biologicals. 2008. PMID: 18757211 No abstract available.

10

Mode of action of adjuvants: implications for vaccine safety and design.

Mastelic B, Ahmed S, Egan WM, Del Giudice G, Golding H, Gust I, Neels P, Reed SG, Sheets RL, Siegrist CA, Lambert PH. Mastelic B, et al. Biologicals. 2010 Sep;38(5):594-601. doi: 10.1016/j.biologicals.2010.06.002. Epub 2010 Jul 24. Biologicals. 2010. PMID: 20659806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page